SK bioscience and CEPI Sign Agreement to Develop mRNA Vaccines
- Written by PR Newswire
- CEPI supports up to 40 mil. USD for early development of mRNA vaccine platform to SK bioscience; up to a further 100 mil. could be made available for late-stage development.
- SK bioscience to secure new vaccines and establish pandemic response system
- SK bioscience to enhance human health by successfully developing innovative vaccines with global...
